Fidelity SPDR Advertisement
Home > Boards > Free Zone > Welcome to Investors Hub > The Question and Answer Board (IHUB)

iHub certainly seems to attract more than its

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Rev Kilgore Mullet Member Profile
 
Followed By 44
Posts 5,305
Boards Moderated 2
Alias Born 11/01/07
160x600 placeholder
Roche Hit By Failure Of Cancer Drug Trial
Roche said a late-stage study of its breast cancer drug Kadcyla failed to yield superior results to an existing treatment, damaging the outlook for stronger sales in one of its key drug markets.
More Top Equities Stories Of The Day
Deezer Names New CEO Before Full U.S. Launch
How a Memo Cost Big Banks $37 Billion
Liberty Media's CommerceHub Acquires E-Commerce Adviser Mercent
Nike Sees Jump in Sales, Growth Concerns -- 4th Update
ADR Shares End Lower; BT Group Shares Trade Actively
Joy Global's Joyless Year -- Ahead of the Tape
Hungary to Sell MKB Bank After Revamp by Central Bank - Prime Minister
Norway Central Bank to Decide Oil Fund Exclusions
Rev Kilgore Mullet   Saturday, 03/17/12 10:23:54 AM
Re: Churak post# 158874
Post # of 175468 
iHub certainly seems to attract more than its fair share of clinical psychopaths. If you believe in free markets, do you think that Adam Smith's invisible hand restrains these people in any way or do you think that bureaucratic intrusions, such as occasionally sending the worst of the lot to the iHub jail, is in any way effective?

The only thing more sad than losing money in a pump is doubling down and being taken to the cleaners for a second trip.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist